Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pittrow

Showing results (101-110 of 150) with videos related to

Pageof 15
Sort By:
European Journal of Endocrinology|January 31, 2008
Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patientsHarald Jörn Schneider, Jens Klotsche, Bernhard Saller, et al.
Medizinische Klinik (Munich, Germany : 1983)|August 10, 2006
[Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care]David Pittrow, Günther Karl Stalla, Andreas M Zeiher, et al.
Arthritis and Rheumatism|June 3, 2008
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysisOliver Distler, Frank Behrens, David Pittrow, et al.
The European Respiratory Journal|May 6, 2020
Risk stratification in pulmonary arterial hypertension using Bayesian analysisManreet K Kanwar, Mardi Gomberg-Maitland, Marius Hoeper, et al.
Blood Pressure|June 9, 2004
HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patientsU Muscha Steckelings, Martina Stoppelhaar, Arya M Sharma, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2010
The predictive value of different measures of obesity for incident cardiovascular events and mortalityHarald J Schneider, Nele Friedrich, Jens Klotsche, et al.
Annals of the Rheumatic Diseases|May 18, 2010
Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT groupJérôme Avouac, Otylia Kowal-Bielecka, David Pittrow, et al.
Steroids|November 1, 2011
Improved prediction of all-cause mortality by a combination of serum total testosterone and insulin-like growth factor I in adult menNele Friedrich, Harald J Schneider, Robin Haring, et al.
Arthritis Research & Therapy|June 25, 2011
Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are neededChristopher P Denton, Jerome Avouac, Frank Behrens, et al.
The Journal of Rheumatology|October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Pageof 15

Showing results (101-110 of 150) with videos related to

Sort By:
Pageof 15
European Journal of Endocrinology|January 31, 2008
Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patientsHarald Jörn Schneider, Jens Klotsche, Bernhard Saller, et al.
Medizinische Klinik (Munich, Germany : 1983)|August 10, 2006
[Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care]David Pittrow, Günther Karl Stalla, Andreas M Zeiher, et al.
Arthritis and Rheumatism|June 3, 2008
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysisOliver Distler, Frank Behrens, David Pittrow, et al.
The European Respiratory Journal|May 6, 2020
Risk stratification in pulmonary arterial hypertension using Bayesian analysisManreet K Kanwar, Mardi Gomberg-Maitland, Marius Hoeper, et al.
Blood Pressure|June 9, 2004
HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patientsU Muscha Steckelings, Martina Stoppelhaar, Arya M Sharma, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2010
The predictive value of different measures of obesity for incident cardiovascular events and mortalityHarald J Schneider, Nele Friedrich, Jens Klotsche, et al.
Annals of the Rheumatic Diseases|May 18, 2010
Validation of the 6 min walk test according to the OMERACT filter: a systematic literature review by the EPOSS-OMERACT groupJérôme Avouac, Otylia Kowal-Bielecka, David Pittrow, et al.
Steroids|November 1, 2011
Improved prediction of all-cause mortality by a combination of serum total testosterone and insulin-like growth factor I in adult menNele Friedrich, Harald J Schneider, Robin Haring, et al.
Arthritis Research & Therapy|June 25, 2011
Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are neededChristopher P Denton, Jerome Avouac, Frank Behrens, et al.
The Journal of Rheumatology|October 4, 2011
Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Otylia Kowal-Bielecka, Jerome Avouac, David Pittrow, et al.
Pageof 15